any adverse event; the most common being headache 
and nausea.2
While pharmacologic countermeasures play an impor-
tant role, sleep experts have emphasized that behavioral 
and operational strategies remain foundational.
“The most effective approaches are not pharmaco-
logic—they’re behavioral, environmental, and systems-
level,” said Michael Grandner, PhD, a sleep researcher 
at the University of Arizona and director of its Sleep 
and Health Research Program. Grandner, who was not 
involved in the review, emphasized that the goal is to 
reduce the need to “fight” sleep in the first place by pri-
oritizing adequate sleep opportunity and minimizing cir-
cadian disruption.
When fatigue cannot be avoided, relatively simple 
interventions remain among the most effective, he 
said. “Short, planned naps, especially when paired with 
caffeine, consistently show meaningful improvements in 
alertness and performance,” Grandner said. Caffeine, he 
added, remains “the most scalable and evidence-based 
pharmacologic tool,” given its rapid onset, predictability 
and relative safety when used strategically.
At the same time, both the review and Grandner 
emphasize an important limitation: no intervention fully 
restores performance to well-rested levels. As he noted, 
“the key point is that no intervention fully restores per-
formance to well-rested levels,” underscoring the need 
for layered, multifaceted strategies rather than reliance 
on any single countermeasure.
Individual Variability and Operational 
Constraints
The review highlighted that the effectiveness of fatigue 
countermeasures is influenced by individual factors such 
as baseline sleep quality, circadian rhythm, and fatigue 
vulnerability. It also suggests that individuals more 
vulnerable to fatigue may derive greater benefit from 
stimulants.
At the same time, operational constraints often limit 
the ability to implement ideal fatigue mitigation strat-
egies. Military missions frequently require extended 
wakefulness or irregular schedules that cannot be eas-
ily modified, reinforcing the need for flexible, adaptive 
approaches tailored to mission demands.
The review also pointed to emerging technologies 
that may help address some of these challenges. Tools 
such as real-time fatigue monitoring—including eye-
tracking and cognitive performance metrics—offer the 
potential to detect early signs of impairment and enable 
more proactive intervention.
A Systems-Based Approach to  
Fatigue Management
As the range of available countermeasures expands, 
there is growing recognition that fatigue management 
must be addressed at both the individual and system lev-
els. Overreliance on pharmacologic interventions risks 
shifting responsibility away from operational factors such 
as scheduling, workload and mission design.
Grandner noted that pharmacologic approaches often 
improve subjective alertness more than they restore full 
cognitive performance. “People feel more awake,” he told 
the Compendium of Federal Medicine, “but that can mask 
persistent deficits in higher-order functioning like judg-
ment, decision-making, and risk assessment,” creating a 
risk of overconfidence in high-stakes environments.
He also emphasized that these medications do not 
resolve the underlying biology of sleep loss. Instead, they 
might delay or blunt fatigue while allowing sleep debt to 
accumulate over time, potentially disrupting recovery 
and reinforcing schedules that are not physiologically 
sustainable.
More broadly, Grandner warned of a systems-level con-
cern: “instead of fixing schedules or reducing fatigue expo-
sure, we ask individuals to compensate pharmacologically.”
Ultimately, the review reinforced that no single inter-
vention is sufficient. Effective fatigue management in mili-
tary aviation requires a coordinated strategy that prioritizes 
sleep, integrates behavioral and pharmacologic approaches, 
and accounts for the realities of operational environments. 
The 2025 VA/DoD clinical guidelines for sleep apnea rec-
ommend solriamfetol as a pharmacotherapy option for 
patients with OSA-related sleepiness.
As new therapies and technologies continue to 
emerge, the challenge will be not only improving 
individual alertness but also designing systems that 
reduce fatigue risk at its source—ensuring that both 
performance and safety are maintained under demanding 
conditions. 
1 Attiah Alzahrani A, Alessa MF, Musaad Alharbi F, Mohammed Alo-
taibi T. Efficacy of Fatigue Countermeasures on Cognitive Performance 
and Operational Safety in Military Pilots: A Systematic Review. Cureus. 
2025 Oct 31;17(10):e95823. doi: 10.7759/cureus.95823. PMID: 41328140; 
PMCID: PMC12665280.
2 Zitting KM, Gilmore KR, Lockyer BJ, Leary EB, et. Al. Solriamfetol for 
Excessive Sleepiness in Early-Morning Shift Work Disorder. NEJM Evid. 
2026 Feb;5(2):EVIDoa2500190. doi: 10.1056/EVIDoa2500190. Epub 2026 
Jan 27. PMID: 41590992.
	
	
2 0 2 6  C O M P E N D I U M  O F  F E D E R A L  M E D I C I N E  
8 5
Effective fatigue management 
requires a coordinated strategy.

View this content as a flipbook by clicking here.